MedCity News

How is Oracle Health’s Nurse AI Agent Different?

Amgen Drug Meets Goals of Key Test in Common Autoimmune Disease With No Approved Meds

Amgen’s dazodalibep led to statistically significant and clinically meaningful results, according to preliminary Phase 3 results in Sjögren's disease. This fusion protein could compete against a Novartis antibody under an FDA review that could make it the first Sjögren's therapy.

By Frank Vinluan

MedCity Influencers

AI Workers Need a Probation Period, Not Just a Pilot

Healthcare leaders know how to test software. We don't yet have a shared playbook for onboarding agents expected to do a job end to end. That is the gap a probation period is meant to fill.

By Jost-Vincent Steiskal

BioPharma, Pharma

Radiopharmaceutical Dealmaking Continues With Telix’s $1.65B ITM Acquisition

Telix Pharmaceuticals is acquiring Isotope Technologies Munich, or ITM, in a $1.65 billion stock deal that will create a radiopharmaceuticals company with greater global scale. ITM’s lead pipeline asset is in late-stage development for a type of gastrointestinal cancer, where it could compete against Novartis and Curium Pharma products.

By Frank Vinluan

Latest Video

Latest News

Health Tech

A man surrounded with butterflies and sunshine in his mind

Array Behavioral Care Unveils New Triage Model

Array Behavioral Care launched a new service to help providers assess patients with urgent behavioral health needs and connect them to appropriate care.

By Marissa Plescia

Artificial Intelligence

doctor man holds a tablet uses Chat GPT on virtual screen for checking disease in laboratory of hospital. virtual x-ray from Chat GPT shows analysis disease. physician do diagnostic infections with Ai

How AI Is Transforming Clinical Documentation at Intermountain Health

Since implementing AI clinical documentation improvement (CDI) tools, Intermountain has seen a 22% point increase in inpatient chart completion during or immediately after rounds.

By Zoe Cunniffe

Opinion

The Nurse Is Health Care’s Most Underpriced Founder

They see the problem first, build the fix, and decide whether it is ever adopted. The market has trained them to hide the one credential that de-risks the deal.

By Beth A. Brooks and Dan Weberg

BioPharma, Pharma

Electra’s Upsized IPO Lands $350M for New Class of Precision Immunology Drugs

Electra Therapeutics’ IPO cash will support a potential first-in-class drug whose lead indication is a rare hyperinflammatory disorder with no FDA-approved treatments. Meanwhile, clinical-stage biotechs Marea Therapeutics and Sensorion revealed their respective plans to enter the U.S. public markets.

By Frank Vinluan

Health Tech

Angle Health Raises $600M to Grow Employer Health Benefits Platform

Angle Health's funding round was led by Vitruvian Partners, with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital and Y Combinator.

By Marissa Plescia

Providers, Policy

RFK Jr. Overhauls USPSTF Leadership: 5 Things to Know

HHS Secretary Robert F. Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force this week, completing the 16-seat panel amid ongoing tension over its leadership.

By Katie Adams

MedCity Influencers

Hackers work secretly in secret rooms. Mysterious colored lights Breaking into personal security and various agencies in the world . Wanted Hacker using computer for hacking in the cyber data center .

Two Years After the Change Healthcare Cyberattack, Healthcare Still Has a Clearinghouse Redundancy Problem

What happened was not just a cybersecurity failure, it was an infrastructure failure.

By Nihal Titan

MedCity Influencers

Why Pharma Companies Should Look To Social Media For Better Patient Insight

Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.

By Rohit Marwah

MedCity Influencers

The Trials Were Always There — Patients Just Couldn’t Find Them

This structural problem calls for a structural solution, requiring no new science, regulation, or data.

By Yuchen Gan

Health Tech

Spotlight Circle Light Focus on the Coin Slot of a Pink Colored Piggy Bank on Pink Background Directly Above View.

Ayble Health Secures $16M for Virtual Digestive Health Clinic

Ayble Health’s Series A round was led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx and Accomplice.

By Marissa Plescia

BioPharma, Pharma

Ultragenyx Gene Therapy Is First Approved Treatment for Rare Neuro Disease Sanfilippo

Ultragenyx Pharmaceutical’s Fayuvi is now the first FDA-approved therapy for the underlying cause of Sanfilippo syndrome type A, an ultra-rare inherited neurological disorder. It’s the second approved gene therapy for Ultragenyx, which specializes in rare disease medicines.

By Frank Vinluan

Providers, Policy, Health Tech, Payers

CMS Broadens ACCESS Model to New Chronic Conditions

CMS will expand its ACCESS model starting in spring 2027 to cover heart failure, COPD, substance use disorders and tobacco cessation. The outcomes-based payment model, which launched in July with 160 participating providers, will now make roughly three in four Medicare beneficiaries eligible for at least one track.

By Katie Adams

MedCity Influencers

Extending ADHD Coverage for the Entire Active Day

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ever-busy and demanding lives of patients, families, and caregivers.

By Matthew Brams and Raul Silva

Events, Consumer / Employer

The Shifting Role of Wearables in Healthcare

The INVEST Digital Health conference, which will spotlight the consumer influence in healthcare, will include a discussion on wearables. It is scheduled for October 29 at Pegasus Park in Dallas. Register today!

By Stephanie Baum

Policy

Trump’s $500 ACA Refunds: ‘We Shouldn’t Confuse a Check With a Healthcare Affordability Strategy’

Trump’s $500 ACA refunds offer immediate financial relief to some enrollees, but healthcare experts question whether they address the broader affordability challenges facing Americans.

By Marissa Plescia

BioPharma, Pharma

North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug

North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific antibody offers efficacy and tolerability advantages over Sanofi’s immune disorder juggernaut, Dupixent.

By Frank Vinluan